Novara Therapeutics
PrivateLast Round
Joint Venture
Aug 26, 2020
Company Overview
Novara Therapeutics operates in Healthcare & Life Sciences and is based in London. It was founded in 2020.
Novara Therapeutics is a life sciences company that develops bone-targeting contrast agents for the diagnosis and treatment of bone fractures and osteoporosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Imaging, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novara Therapeutics Comparables
Compare Novara Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quince Therapeutics | 78% | |
| Taithera, Inc. | 71% | |
| Skeletalis Bio | 65% |
For institutional investors. Book with your work email.
Novara Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Novara Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Embryo Ventures | Joint Venture |
| Orthopaedic Research UK | Joint Venture |
Novara Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Novara Therapeutics's valuation, stock price, and market status.
Is Novara Therapeutics a public or private company?
Novara Therapeutics is a private company.
What is the current stock price of Novara Therapeutics?
Novara Therapeutics is a private company, so its shares have no public market price. Caplight tracks Novara Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Novara Therapeutics worth (valuation)?
Valuation information for Novara Therapeutics is not publicly available.
Can I buy Novara Therapeutics stock?
Novara Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Novara Therapeutics's last funding round?
Novara Therapeutics's most recent funding round was Joint Venture on August 26, 2020.
Who are the main investors in Novara Therapeutics?
Key investors in Novara Therapeutics include Embryo Ventures, Orthopaedic Research UK.
Will Novara Therapeutics IPO soon?
No public IPO plans have been announced for Novara Therapeutics.
How can I track Novara Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Novara Therapeutics's shares on secondary markets.